Xiangyu Ling

机构：Qiqihar University, Chinese Academy of Medical Sciences & Peking Union Medical College, National Health and Family Planning Commission, Peking Union Medical College Hospital, Jiangsu Province Hospital, Collaborative Innovation Center of Chemistry for Energy Materials, Nanjing Medical University

发表论文 32 篇 · 总被引 236 次 · h-index 7

代表论文

• A novel anti-tri-missing rib structure with a central ring for maintaining constant Poisson's ratio under large deformations (2025 · Thin-Walled Structures · 被引 18)
• LRP11 facilitates lipid metabolism and malignancy in hepatocellular carcinoma by stabilizing RACK1 through USP5 regulation (2025 · Molecular Medicine · 被引 10)
• Hypoxia-induced RCOR2 promotes macrophage M2 polarization and CD8 + T-cell exhaustion by enhancing LIF transcription in hepatocellular carcinoma (2025 · Journal for ImmunoTherapy of Cancer · 被引 7)
• Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target (2025 · Cancer Cell International · 被引 4)
• GALNT7 promotes hepatocellular carcinoma progression by activating the PI3K/AKT signaling pathway via O-glycosylation of MUC13 (2025 · Acta Biochimica et Biophysica Sinica · 被引 3)
• The deficiency of ALKBH5 promotes lenvatinib resistance and CD8+ T cell exhaustion via accumulation of the cholesterol metabolite 27HC in hepatocellular carcinoma (2026 · Cancer Letters · 被引 2)